Regeneron Q1 2024 Earnings. In the last quarter regeneron reported $10.731 eps in relation to $11.86 expected by the. An archived and transcript of this call will be available.
First quarter 2022 revenues increased 17% to $2.97 billion versus first quarter 2021; The consensus eps estimate is.
Today Announced That It Will Report Its First Quarter 2024 Financial And Operating Results On Thursday, May 2, 2024, Before The U.s.
In the last quarter regeneron reported $10.731 eps in relation to $11.86 expected by the.
Earnings For Regeneron Pharmaceuticals Are Expected To Grow By 4.04% In The Coming Year, From $38.86 To $40.43 Per Share.
First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023;
Price As Of May 2, 2024, 4:00 P.m.
Images References :
The Street Expects Regeneron To Report Respectable Growth Into The Next Decade Going From An Estimated ~$45 Earnings Per Share For 2024 To Roughly $79.50 In.
Regeneron pharmaceuticals (nasdaq:regn) is scheduled to announce q1 earnings results on thursday, may 2nd, before market open.
Regeneron (Regn) Will Release Its Next Earnings Report On May 2, 2024.
In the last quarter regeneron reported $10.731 eps in relation to $11.86 expected by the.
Thank You For Your Interest In Regeneron And Welcome To Our First Quarter 2024 Earnings Conference Call.
